CIK 0001770069 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MapLight Therapeutics, Inc.
Sign in to watch- Ticker
- MPLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832163243
- Phone
- 650-839-4360
- Business address
- 800 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Alvarado Therapeutics, Inc.
- 4 Open-market sale Chief Scientific Officer sold 18,267 shares at an average $36.88 ($673,636)
- 4 Open-market sale General Counsel sold 16,508 shares at an average $36.82 ($607,870)
- 4 Planned sale Chief Medical Officer sold 47,158 shares at an average $36.78 ($1,734,490)
- 4 Grant or award Director acquired 7,864 shares (grant or award)
- 4 Grant or award Director acquired 7,864 shares (grant or award)
- 4 Grant or award Director acquired 3,932 shares (grant or award)
- 4 Grant or award Director acquired 3,932 shares (grant or award)
- 4 Grant or award Director acquired 3,932 shares (grant or award)
- 4 Grant or award Director acquired 3,932 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Executive Officer sold 118,235 shares at an average $27.19 ($3,215,000)
- 4 Planned sale General Counsel sold 13,917 shares at an average $30.13 ($419,263)
- 4 Planned sale Chief Executive Officer sold 68,491 shares at an average $28.47 ($1,949,634)
- 4 Planned sale Chief Medical Officer sold 4,438 shares at an average $28.54 ($126,640)
- 4 Planned sale Chief Scientific Officer sold 721 shares at $28.28 ($20,390)
- 4 Planned sale Chief Financial Officer sold 36,371 shares at an average $28.17 ($1,024,719)
- 4 Planned sale Chief Medical Officer sold 50,280 shares at an average $28.39 ($1,427,594)
- 4 Planned sale Chief Scientific Officer sold 51,707 shares at an average $28.40 ($1,468,251)
- 4 Planned sale General Counsel sold 13,917 shares at an average $27.89 ($388,177)
Page 2 of 5 · 100 filings